These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32415240)

  • 41. Multimodal imaging based biomarkers predictive of early and late response to anti-VEGFs during the first year of treatment for neovascular age-related macular degeneration.
    Tarakcioglu HN; Ozkaya A; Kemer B; Taskapili M
    J Fr Ophtalmol; 2019 Jan; 42(1):22-31. PubMed ID: 30578008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Geographic atrophy in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
    Xu L; Mrejen S; Jung JJ; Gallego-Pinazo R; Thompson D; Marsiglia M; Freund KB
    Retina; 2015 Feb; 35(2):176-86. PubMed ID: 25387047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MACULAR ATROPHY AND MACULAR MORPHOLOGY IN AFLIBERCEPT-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Kuroda Y; Yamashiro K; Ooto S; Tamura H; Oishi A; Nakanishi H; Miyata M; Hata M; Takahashi A; Wakazono T; Yoshimura N; Tsujikawa A
    Retina; 2018 Sep; 38(9):1743-1750. PubMed ID: 28691937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymorphisms in the APOE gene and the location of retinal fluid in eyes with neovascular age-related macular degeneration.
    Wickremasinghe SS; Sandhu SS; Amirul-Islam FM; Abedi F; Richardson AJ; Baird PN; Guymer RH
    Retina; 2014 Dec; 34(12):2367-75. PubMed ID: 25077528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EFFICACY OF ADJUVANT TOPICAL DORZOLAMIDE-TIMOLOL IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
    Lee JH; Lee SC; Byeon SH; Koh HJ; Kim SS; Lee CS
    Retina; 2019 Oct; 39(10):1953-1958. PubMed ID: 30161096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Baseline Optical Coherence Tomography Findings as Outcome Predictors after Switching from Ranibizumab to Aflibercept in Neovascular Age-Related Macular Degeneration following a Treat-and-Extend Regimen.
    Türksever C; Prünte C; Hatz K
    Ophthalmologica; 2017; 238(3):172-178. PubMed ID: 28772268
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spectral-Domain OCT Analysis of Risk Factors for Macular Atrophy Development in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
    Sadda SR; Abdelfattah NS; Lei J; Shi Y; Marion KM; Morgenthien E; Gune S; Balasubramanian S
    Ophthalmology; 2020 Oct; 127(10):1360-1370. PubMed ID: 32402555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcomes of switching to aflibercept for treatment-resistant neovascular age-related macular degeneration.
    Spooner K; Hong T; Nair R; Chow NCC; Broadhead GK; Wijeyakumar W; Chang AA
    Acta Ophthalmol; 2019 Aug; 97(5):e706-e712. PubMed ID: 30740921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions.
    Gillies M; Arnold J; Bhandari S; Essex RW; Young S; Squirrell D; Nguyen V; Barthelmes D
    Am J Ophthalmol; 2020 Feb; 210():116-124. PubMed ID: 31606444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Ciulla TA; Ying GS; Maguire MG; Martin DF; Jaffe GJ; Grunwald JE; Daniel E; Toth CA;
    Ophthalmology; 2015 Jun; 122(6):1203-11. PubMed ID: 25824327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Twelve-month outcomes of intra-vitreal anti-VEGF agents for treatment-naïve neovascular age-related macular degeneration eyes: French data from the fight for retinal blindness!
    Lestable L; Gabrielle PH; Bron AM; Nguyen P; Creuzot-Garcher C
    J Fr Ophtalmol; 2020 Oct; 43(8):761-769. PubMed ID: 32622633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Onset of Retinal Pigment Epithelium Atrophy Subsequent to Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration.
    Sitnilska V; Altay L; Enders P; Hermann M; Muether PS; Fauser S
    Ophthalmologica; 2019; 241(3):154-160. PubMed ID: 30304737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spatial Correspondence Between Intraretinal Fluid, Subretinal Fluid, and Pigment Epithelial Detachment in Neovascular Age-Related Macular Degeneration.
    Klimscha S; Waldstein SM; Schlegl T; Bogunovic H; Sadeghipour A; Philip AM; Podkowinski D; Pablik E; Zhang L; Abramoff MD; Sonka M; Gerendas BS; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4039-4048. PubMed ID: 28813577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Indocyanine green angiography findings in patients with neovascular age-related macular degeneration refractory to ranibizumab switched to aflibercept.
    Calvo-Gonzalez C; Reche-Frutos J; Fernández-Vigo JI; Donate-López J; Serrano-García I; Fernández-Pérez C
    Int Ophthalmol; 2019 Nov; 39(11):2441-2448. PubMed ID: 30767090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of neovascular age-related macular degeneration with a variable ranibizumab dosing regimen and one-time reduced-fluence photodynamic therapy: the TORPEDO trial at 2 years.
    Spielberg L; Leys A
    Graefes Arch Clin Exp Ophthalmol; 2010 Jul; 248(7):943-56. PubMed ID: 20204659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-related macular degeneration: using morphological predictors to modify current treatment protocols.
    Ashraf M; Souka A; Adelman RA
    Acta Ophthalmol; 2018 Mar; 96(2):120-133. PubMed ID: 29130626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intraretinal, sub-retinal, and sub-retinal pigmented epithelium fluid in non-exudative age-related macular degeneration: follow-up with OCT imaging.
    Samanta A; Jhingan M; Arora S; Singh S; Tucci D; Cagini C; Lupidi M; Chhablani J
    Eur J Ophthalmol; 2022 Jul; 32(4):2419-2426. PubMed ID: 34340599
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrence Rate of Choroidal Neovascularization in Neovascular Age-Related Macular Degeneration Managed with a Treat-Extend-Stop Protocol.
    Adrean SD; Chaili S; Grant S; Pirouz A
    Ophthalmol Retina; 2018 Mar; 2(3):225-230. PubMed ID: 31047590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiography.
    Maruyama-Inoue M; Sato S; Yamane S; Kadonosono K
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2089-2096. PubMed ID: 30173338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
    Sadda SR; Tuomi LL; Ding B; Fung AE; Hopkins JJ
    Ophthalmology; 2018 Jun; 125(6):878-886. PubMed ID: 29477692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.